Philip J. Whitcome

Philip J.
Whitcome, Ph.D., has served as a director of Avigen since December 1992.
In April 1995, Dr. Whitcome was elected Chairman of the Board and from March 1996 to December 1996 he served as acting Chief Financial Officer.
From 1988 to 1994, Dr. Whitcome was President and Chief Executive Officer of Neurogen Corporation, a biopharmaceutical company.
From 1981 to 1988, Dr. Whitcome was employed at Amgen Inc., a biopharmaceutical company, including service as Director of Strategic Planning.
Prior to joining Amgen, he served as Manager of Corporate Development for Medical Products at Bristol-Myers Squibb Company, a pharmaceutical and healthcare products company, and held research and marketing management positions with the Diagnostics Division of Abbott Laboratories, a pharmaceutical and medical products company.
Dr. Whitcome holds a Ph.D.
in Molecular Biology from the University of California at Los Angeles, an M.B.A.
from the Wharton School at the University of Pennsylvania and a B.S.
in Physics from Providence College.